Fig. 6From: Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulationsCorrelation prediction of Hypo1 between the test set and the training set compoundsBack to article page